Miglitol

Miglitol is an oral medication used for the management of type 2 diabetes mellitus. It belongs to a class of drugs called alpha-glucosidase inhibitors, which work by slowing down the digestion of carbohydrates in the small intestine, thereby reducing the absorption of glucose into the bloodstream.
Miglitol is typically prescribed as an adjunct to diet and exercise in patients with type 2 diabetes who require additional glycemic control. It is not recommended for use in patients with type 1 diabetes or diabetic ketoacidosis.
When taken as directed, Miglitol can help lower blood glucose levels after meals, improving overall glycemic control. Miglitol does not lower blood glucose levels between meals, and it does not replace the need for regular monitoring of blood glucose levels.
Miglitol is available in tablet form and is typically taken three times daily, immediately before each meal. The recommended starting dose is 25 mg, and the dose may be increased to 50 mg if needed, based on individual response and tolerability.
Common side effects of Miglitol include gastrointestinal symptoms such as flatulence, diarrhea, abdominal discomfort, and bloating. These side effects are generally mild and tend to resolve over time as the body adjusts to the medication.